Dr Pauline Williams, former Head of Global Health R&D at GSK, was recently appointed chair of DNDi’s Scientific Advisory Committee, composed of prominent drug development scientists and public health experts who provide independent and exclusively evidence-driven guidance on all DNDi R&D programmes. We sat down with Dr Williams to get her perspective on why the SAC’s scientific opinions are so crucial to our work – along with her views on non-profit medical R&D, current shifts in the global health innovation ecosystem, and how organizations like DNDi can tackle future challenges.

You can also listen to the audio version of this interview on our podcast channel: